Preoperative Medical Testing and Falls in Medicare Beneficiaries Awaiting Cataract Surgery.

Ophthalmology

Department of Medicine, Informatics, and Health Policy & Management, Schools of Medicine and Public Health and Institute for Health Informatics, University of Minnesota, Minneapolis, Minnesota; Minneapolis VA Medical Center, Minneapolis, Minnesota.

Published: February 2021

AI Article Synopsis

  • The study investigates whether routine preoperative testing for cataract surgery leads to delays that increase the risk of falls among Medicare beneficiaries aged 66 and older.
  • Results show that patients of high-testing physicians were more likely to wait longer for surgery and had a 43% higher incidence of falls within 90 days following ocular biometry compared to those under low-testing physicians.
  • Despite the increased odds of falls in high-testing patients, after controlling for the waiting time for surgery, the difference in fall risk diminished, suggesting that the delay itself could be a significant factor.

Article Abstract

Purpose: Delaying cataract surgery is associated with an increased risk of falls, but whether routine preoperative testing delays cataract surgery long enough to cause clinical harm is unknown. We sought to determine whether the use of routine preoperative testing leads to harm in the form of delayed surgery and falls in Medicare beneficiaries awaiting cataract surgery.

Design: Retrospective, observational cohort study using 2006-2014 Medicare claims.

Participants: Medicare beneficiaries 66+ years of age with a Current Procedural Terminology claim for ocular biometry.

Methods: We measured the mean and median number of days between biometry and cataract surgery, calculated the proportion of patients waiting ≥ 30 days or ≥ 90 days for surgery, and determined the odds of sustaining a fall within 90 days of biometry among patients of high-testing physicians (testing performed in ≥ 75% of their patients) compared with patients of low-testing physicians. We also estimated the number of days of delay attributable to high-testing physicians.

Main Outcome Measures: Incidence of falls occurring between biometry and surgery, odds of falling within 90 days of biometry, and estimated delay associated with physician testing behavior.

Results: Of 248 345 beneficiaries, 16.4% were patients of high-testing physicians. More patients of high-testing physicians waited ≥ 30 days and ≥ 90 days to undergo surgery (31.4% and 8.2% vs. 25.0% and 5.5%, respectively; P < 0.0001 for both). Falls before surgery in patients of high-testing physicians increased by 43% within the 90 days after ocular biometry (1.0% vs. 0.7%; P < 0.0001). The adjusted odds ratio of falling within 90 days of biometry in patients of high-testing physicians versus low-testing physicians was 1.10 (95% confidence interval [CI], 1.03-1.19; P = 0.008). After adjusting for surgical wait time, the odds ratio decreased to 1.07 (95% CI, 1.00-1.15; P = 0.06). The delay associated with having a high-testing physician was approximately 8 days (estimate, 7.97 days; 95% CI, 6.40-9.55 days; P < 0.0001). Other factors associated with delayed surgery included patient race (non-White), Northeast region, ophthalmologist ≤ 40 years of age, and low surgical volume.

Conclusions: Overuse of routine preoperative medical testing by high-testing physicians is associated with delayed surgery and increased falls in cataract patients awaiting surgery.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443237PMC
http://dx.doi.org/10.1016/j.ophtha.2020.09.013DOI Listing

Publication Analysis

Top Keywords

high-testing physicians
24
patients high-testing
20
cataract surgery
16
days biometry
16
≥ days
16
days
13
medicare beneficiaries
12
surgery
12
routine preoperative
12
delayed surgery
12

Similar Publications

Article Synopsis
  • Germline genetic testing (GT) is recommended for ovarian cancer (OC) and some endometrial cancer (EC) patients, but participation is low due to various barriers.
  • A quality improvement study at a medical center tracked 116 newly diagnosed OC/EC patients, achieving high GT rates (91% for OC, 75% for EC) and rapid result availability.
  • Identified barriers include missed recommendations, patient overwhelm, financial/privacy concerns, and language issues; the study suggests enhancing GT encouragement throughout treatment and offering multilingual digital consent options.
View Article and Find Full Text PDF

Purpose: Racial/ethnic inequities in next-generation sequencing (NGS) were examined for patients with advanced non-small-cell lung cancer (aNSCLC) at the practice and physician levels to inform policies to improve equitable quality of care.

Methods: This retrospective study used a nationwide electronic health record-derived deidentified database for patients with aNSCLC diagnosed between April 2018 and March 2022 in the community setting. Timely NGS was an NGS result between initial diagnosis and ≤60 days after advanced diagnosis.

View Article and Find Full Text PDF

Background: Access to HIV testing is crucial for detection, linkage to treatment, and prevention. In less urbanised areas, reliance on general practitioners (GPs) for HIV testing is probable, as sexual health centres (SHC) are mostly located within urbanised areas. Limited insight into individuals undergoing HIV testing stems from sparse standard registration of demographics at GPs.

View Article and Find Full Text PDF

Genomic testing among patients with newly diagnosed advanced non-small cell lung cancer in the United States: A contemporary clinical practice patterns study.

Lung Cancer

May 2022

INSERM UMR 1068, CNRS UMR 725, Centre de Recherche en Cancérologie de Marseille (CRCM), Aix-Marseille Université, Marseille, France; Department of Multidisciplinary Oncology and Innovative Therapeutics, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France; Gustave Roussy Cancer Campus, Villejuif, France.

Objectives: According to 2018 United States and international lung cancer and pathology guidelines, testing of EGFR, ALK, ROS1 and BRAF genes is a minimum requirement to identify targeted therapy options in patients with advanced non-small cell lung cancer (aNSCLC). We describe real-world use and clinical features of next-generation sequencing (NGS) and other non-NGS testing technologies in these patients.

Materials And Methods: Patients were from the Flatiron Health electronic health record-derived de-identified database and were newly diagnosed with non-squamous aNSCLC between 1 January 2018 and 30 June 2019.

View Article and Find Full Text PDF

Did changes to recommended testing criteria affect the rate of vitamin D testing among Australian women.

Arch Osteoporos

October 2020

NHMRC Centre for Research Excellence on Women and Non-communicable Diseases (CREWaND), School of Public Health, The University of Queensland, Herston Road, Herston, QLD, 4006, Australia.

Unlabelled: We examine whether new government criteria designed to reduce overuse of vitamin D testing changed testing rates in Australian women. Although testing initially declined, the reduction was not sustained. Women who had more doctor visits and who had been tested previously were more likely to have vitamin D testing.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!